These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27076138)

  • 21. Replicating-Competent VSV-Vectored Pseudotyped Viruses.
    Yuan F; Zheng A
    Adv Exp Med Biol; 2023; 1407():329-348. PubMed ID: 36920706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.
    Tober R; Banki Z; Egerer L; Muik A; Behmüller S; Kreppel F; Greczmiel U; Oxenius A; von Laer D; Kimpel J
    J Virol; 2014 May; 88(9):4897-907. PubMed ID: 24554655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach.
    Chattopadhyay A; Rose JK
    J Virol; 2011 Mar; 85(5):2004-11. PubMed ID: 21177820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.
    Lo MK; Bird BH; Chattopadhyay A; Drew CP; Martin BE; Coleman JD; Rose JK; Nichol ST; Spiropoulou CF
    Antiviral Res; 2014 Jan; 101():26-9. PubMed ID: 24184127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single-point mutation in the rubella virus E1 glycoprotein promotes rescue of recombinant vesicular stomatitis virus.
    Das PK; Gonzalez PA; Jangra RK; Yin P; Kielian M
    mBio; 2024 Mar; 15(3):e0237323. PubMed ID: 38334805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activity.
    van den Pol AN; Davis JN
    J Virol; 2013 Jan; 87(2):1019-34. PubMed ID: 23135719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector.
    Publicover J; Ramsburg E; Rose JK
    J Virol; 2005 Nov; 79(21):13231-8. PubMed ID: 16227246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion.
    Wongthida P; Jengarn J; Narkpuk J; Koonyosying P; Srisutthisamphan K; Wanitchang A; Leaungwutiwong P; Teeravechyan S; Jongkaewwattana A
    PLoS One; 2016; 11(6):e0157287. PubMed ID: 27315286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.
    Kahn JS; Roberts A; Weibel C; Buonocore L; Rose JK
    J Virol; 2001 Nov; 75(22):11079-87. PubMed ID: 11602747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation.
    Marzi A; Menicucci AR; Engelmann F; Callison J; Horne EJ; Feldmann F; Jankeel A; Feldmann H; Messaoudi I
    Front Immunol; 2018; 9():3071. PubMed ID: 30723475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.
    Kim GN; Wu K; Hong JP; Awamleh Z; Kang CY
    J Virol; 2015 Jun; 89(12):6338-51. PubMed ID: 25855732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice.
    Johnson JE; McNeil LK; Megati S; Witko SE; Roopchand VS; Obregon JH; Illenberger DM; Kotash CS; Nowak RM; Braunstein E; Yurgelonis I; Jansen KU; Kalyan NK; Sidhu MK
    Immunol Lett; 2013 Feb; 150(1-2):134-44. PubMed ID: 23261719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of Filovirus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus for Study of Filovirus Entry Mechanisms.
    Brouillette RB; Maury W
    Methods Mol Biol; 2017; 1628():53-63. PubMed ID: 28573610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recoding of the vesicular stomatitis virus L gene by computer-aided design provides a live, attenuated vaccine candidate.
    Wang B; Yang C; Tekes G; Mueller S; Paul A; Whelan SP; Wimmer E
    mBio; 2015 Mar; 6(2):. PubMed ID: 25827413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced oncolytic activity of vesicular stomatitis virus encoding SV5-F protein against prostate cancer.
    Chang G; Xu S; Watanabe M; Jayakar HR; Whitt MA; Gingrich JR
    J Urol; 2010 Apr; 183(4):1611-8. PubMed ID: 20172545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vesicular stomatitis virus (VSV) as a vaccine vector for immunization against viral infections].
    Tomczyk T; Orzechowska B
    Postepy Hig Med Dosw (Online); 2013 Jan; 67():1345-58. PubMed ID: 24379275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tracking the Fate of Genetically Distinct Vesicular Stomatitis Virus Matrix Proteins Highlights the Role for Late Domains in Assembly.
    Soh TK; Whelan SP
    J Virol; 2015 Dec; 89(23):11750-60. PubMed ID: 26339059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host.
    Martinez I; Barrera JC; Rodriguez LL; Wertz GW
    Vaccine; 2004 Sep; 22(29-30):4035-43. PubMed ID: 15364454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute reactogenicity after intramuscular immunization with recombinant vesicular stomatitis virus is linked to production of IL-1β.
    Athearn K; Sample CJ; Barefoot BE; Williams KL; Ramsburg EA
    PLoS One; 2012; 7(10):e46516. PubMed ID: 23056330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.